Compare Abeona Therapeutics Inc (ABEO) vs C3.ai Inc (AI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs C3.ai Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while C3.ai Inc trades at $10.59 (market cap $1.65B). The key difference: C3.ai Inc is far larger — about 3.9× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, C3.ai Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | AI | |
|---|---|---|
Market Cap | $421.19M | $1.65B |
Sector | Health | Technology |
52-Week High | $7.45 | $19.66 |
52-Week Low | $4.17 | $7.76 |
Enterprise Value | $276.10M | $1.08B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About C3.ai Inc
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Read more on AI →
